Respiratorna infekcija gornjih dišnih putova praćena istovremeno Sweetovim sindromom i nodoznim eritemom by Alemka Markotić et al.
RAD 540. Medical Sciences 48-49 (2019) :                                  December 2019   -   www.rad-med.com71
Upper Respiratory Infection Followed 
by Concurrent Sweet’s Syndrome 
and Erythema Nodosum
Alemka Markotić1,2,3     , Ivana Puškarić1, Tomislava Skuhala1,4
1 University Hospital for Infectious Diseases „Dr. Fran Mihaljević“, Zagreb, Croatia
2 School of Medicine, University of Rijeka, Rijeka, Croatia
3 Catholic University of Croatia, Zagreb, Croatia
4 School of Dental Medicine, University of Zagreb, Zagreb, Croatia
AbstrAct:
Sweet’s syndrome (SS) is a rare inflammatory condition presented with fever, leukocytosis, ery-
thematous, tender plaques and histology evidence of dense neutrophilic infiltration in the dermis. 
It appears mostly in women between age 30-60 years. Erythema nodosum (EN), a form of pan-
niculitis, is manifested as erythematous painful rounded lumps and occurs 3-5 times more often 
in female patients in all age groups, but mostly between the second and the fourth decades of life. 
Although rare, concurrent occurrence of Sweet’s syndrome and erythema nodosum is described 
and may be associated with autoimmune disorders, certain malignancies, gastrointestinal disease or 
upper respiratory tract infections. Here, we described 34-year-old saleswoman who developed con-
current Sweet’s syndrome and erythema nodosum seven days after upper respiratory tract infection 
onset. During upper respiratory infection, she was treated with three-days azithromycin therapy, 
together with ibuprofen and paracetamol. Later, when she developed concurrent SS and EN, she 
was treated initially with clindamycin and prednisone 40 mg, followed by 60 mg of prednisone 
after which the patient becomes afebrile with gradual rash regression. There is limited knowledge 
on concurrent SS and EN, their etiopathogenesis and association with different diseases, infections 
and /or medications. Concurrent SS and EN in our patient was probably triggered by the upper 
respiratory tract infection. Although, there is no evidence that azithromycin may induce SS or EN 
or both, it could be considered as a possible trigger alone or together with the upper respiratory 
tract infection.
Keywords: upper respiratory infection, pharyngitis, Sweet’s syndrome, erythema nodosum, azith-
romycin
Sažetak:
RespiRatoRna infekcija goRnjih dišnih putova pRaćena istovRemeno sweetovim sindRomom i 
nodoznim eRitemom
Sweetov sindrom (SS) rijetko je upalno stanje koje se manifestira vrućicom, leukocitozom, eritem-
atoznim, nježnim plakovima i histološkim dokazom guste neutrofilne infiltracije u dermisu. Pojavl-
juje se uglavnom u žena u dobi od 30-60 godina. Nodozni eritem (EN), oblik panikulitisa, očituje 
se bolnim, eritematoznim, zaobljenim potkožnim čvorovima i javlja se 3-5 puta češće u bolesnica u 
svim dobnim skupinama, ali uglavnom između drugog i četvrtog desetljeća života. Iako je rijetka, 
istodobna pojava Sweet-ovog sindroma i nodoznog eritema opisana je i može biti povezana s autoi-
munim poremećajima, određenim malignim bolestima, gastrointestinalnom bolešću ili infekcijama 
gornjih dišnih putova. Ovdje smo opisali 34-godišnju prodavačicu koja je razvila istodobni Sweetov 
sindrom i nodozni eritem sedam dana nakon početka infekcije gornjih dišnih putova. Tijekom infek-
cije gornjih dišnih puteva, liječena je trodnevnom terapijom azitromicinom, zajedno s ibuprofenom 
i paracetamolom. Kasnije, kad je razvila istodobno SS i EN, liječena je u početku klindamicinom i 
prednizonom od 40 mg, a zatim sa 60 mg prednizona, nakon čega bolesnica postaje afebrilna s pos-
tupnom regresijom osipa. Malo se zna o istodobnom SS i EN, njihovoj etiopatogenezi i povezanosti 
s različitim bolestima, infekcijama i / ili lijekovima. Istodobni SS i EN u naše bolesnice vjerojatno je 
potaknut infekcijom gornjih dišnih puteva. Iako nema dokaza da azitromicin može izazvati SS ili EN 
ili oboje, moglo bi se pretpostaviti da bi mogao biti okidač sam ili zajedno s infekcijom gornjih dišnih 
puteva.
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introduction
Upper respiratory tract infections (URI) include the infection in 
nose, sinuses, pharynx, larynx, and the large airways and are leading 
cause of morbidity. Usually, they are caused by different viruses, 
mostly rhinoviruses, but also the influenza virus, adenovirus, entero-
virus, and respiratory syncytial virus. Bacterial infections are also 
common and often pharyngitis could be caused by Streptococcus 
pyogenes, a Group A streptococcus1,2. 
Sweet’s syndrome (SS) is a rare inflammatory condition presented 
with fever, leukocytosis erythematous, tender plaques and histology 
evidence of dense neutrophilic infiltration in the dermis. Different 
diseases, including infectious diseases, malignancies and medications 
are associated with SS. It appears mostly in women between age 
30-60 years3-5. There are major and minor criteria for diagnosis of 
SS (Figure 1)6,7. For the treatment of patients with Sweet’s syn-
drome systemic corticosteroids have been considered the primary 
option, but iodide or colchicine can also result in rapid resolution 
symptoms and lesions. In case that corticosteroids are contraindi-
cated, indomethacin, clofazimine, dapsone, and cyclosporine can be 
administered3,4.
Erythema nodosum (EN), a form of panniculitis, is manifested 
as erythematous painful rounded lumps, 1-6 cm in diameter and 
occurs 3-5 times more often in female patients in all age groups, 
but mostly between the second and the fourth decades of life. EN 
is usually located symmetrically on the anterior surface of the lower 
extremities, but can also spread to the upper extremities and neck. It 
does not ulcerate and resolves without scarring. Streptococcal phar-
yngitis is the most common trigger of EN, which appears 2–3 weeks 
after infection resolution. Mycoplasma, Chlamydia, Mycobacteri-
um, Yersinia spp., Coccidioides and Histoplasma caused infections 
could be followed by EN as well. Other medical conditions, which 
could be linked to EN development are: sarcoidosis, medication 
including antibiotics, inflammatory bowel diseases and sometimes 
pregnancy. If an infectious agent triggered EN, antibiotic therapy 
can be administered and non-steroidal anti-inflammatory agents are 
usually given. In case that some medication was responsible for the 
occurrence of EN, it should be stopped. The most common drugs 
that cause erythema nodosum are: oral contraceptives, sulfonamides 
and penicillin. However, despite investigation, no underlying cause 
is found in most erythema nodosum patients8.
Although rare, concurrent occurrence of Sweet’s syndrome and 
erythema nodosum is described and may be associated with auto-
immune disorders, certain malignancies, gastrointestinal disease. A 





histopathologic evidence of  dense 




inflammatory or infectious diseases (upper respiratory 
or gastrointestinal) vaccination or pregnancy
succes on systemic glucocorticosteroid therapy or 
potassium iodide
abnormal clinical laboratory values (three of  four):
1. erythrocyte sedimentation rate >20 mm/h
2. elevated C-reactive protein
3. >8000 leukocytes/µl
4. >70% neutrophils
Figure 1. Figure 1. Major and minor diagnostic criteria for classic Sweet’s syndrome based on fulfilling both major and two of the four minor criteria6,7.
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caSe report
In 34-year-old saleswoman, the disease began eight days before 
admission to the hospital with a sore throat that lasted for the five 
days. On the sixth day after the upper respiratory tract symptoms 
onset, she became febrile up to 40 °C with chills and shivering. Next 
day she noticed a rash on the body and hands with mild pain and she 
was admitted to the hospital day after. Two days before admission she 
completed her three-days azithromycin therapy, taking ibuprofen and 
paracetamol as well. In childhood, she had contracted varicella and 
had lung tuberculosis at the age of 12. She had no chronic illnesses 
and was not taking therapy for chronic illnesses. Her daughter had 
a respiratory, possibly viral infection a week ago. She stated that she 
was allergic to amoxicillin clavulanic acid. 
On admission, she is conscious, febrile (38.5 C), normotensive 
(110/70 mmHg), with neat pulse and respiratory frequency. Round-
ed lumps, suggestive of erythema nodosum were observed on the skin 
of the lower legs of the patient, together with the annular plaques and 
pustules (0.5-1 cm in diameter) developed on the skin of patient’s 
forearm (Figure 2 A, C) and very few at the trunk and neck. The 
conjunctival injection is recorded on both sides. Later, during the 
day, she became highly febrile up to 41 C.
She had high sedimentation rate (70 mm/h) and C-reactive protein 
(CRP) was 197 mg/l, with 8.800 leukocytes/µl. Chest X-ray was 
normal and a slightly enlarged liver and polyp in the gallbladder 
were recorded on an abdominal ultrasound. On the second day of 
hospitalization, a skin biopsy was taken from the annular papule on 
the forearm and histopathologic evidence of neutrophilic infiltration 
in the dermis was confirmed later on. Initially, she was treated with 
clindamycin, and prednisone 40 mg. Three days later, sedimentation 
rate was 40 mm/h and CRP was 70 mg/l. Five days after admission, 
the patient was still febrile up to 38.5 ℃ and the prednisone dose was 
increased to 60 mg, after which the patient becomes afebrile with 
gradual rash regression (Figure 2 B, D). 
diScuSSion
Although etiology of SS or EN are not known, both syndromes 
could be triggered with upper respiratory infections or medications 
and associated with autoimmune or malignant diseases. Both are 
also reactive dermatoses with some similar clinical manifestations 
and histopathological findings, which could be successfully solved 
with corticosteroid therapy 3-5. Concurrent SS and EN are rare, but 
are described in the literature in connection with autoimmune or 
malignant diseases and also some respiratory, mostly streptococcal 
infections9-13.
Here we presented concurrent SS and EN in 34-years old, previous-
ly healthy woman with preceding upper respiratory tract infection 
Figure 2. Rounded lumps (erythema nodosum) on the skin of the patient’s lower leg, three (A) and ten days after the rash onset (B); Annular plaques and pustules developed 
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treated with azithromycin. We presumed that concurrent SS and EN 
in our patient was triggered with respiratory infection, but there is 
also possibility to be induced by antibiotic therapy. There is evidence 
in the literature that SS or EN are associated with some respiratory 
or gastrointestinal infections, including recent description of 29-year 
old Mexican who developed concurrent SS and EN possibly after the 
upper respiratory tract infection9-13. So far, there is no evidence in the 
literature that SS or EN could be induced by ibuprofen or parac-
etamol, which our patient took during the upper respiratory infection. 
Recent publication, however, described SS induced by an oral acet-
aminophen-codeine suspension and tablets, following repair of a facial 
fracture17. Also, no azithromycin therapy was associated with SS or/
and EN so far and here we have no proof that this could be the case in 
our patient as well. Previously it was stated that tetracycline, minocy-
cline, or clindamycin may be associated with SS18,19. The therapy with 
oral prednisone was successful in our patient and skin rash was almost 
completely gone in three weeks of follow up.    
concluSion
There is limited knowledge on concurrent SS and EN, their etio-
pathogenesis and association with different diseases, infections and /or 
medications. Here, we presented a concurrent SS and EN in 34-years 
old women, which was probably triggered by the upper respiratory 
tract infection. Although, there is no evidence that azithromycin may 
induce SS or EN or both, it could be considered as a possible trigger 
alone or together with the upper respiratory tract infection.
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